Sopharma registered 35% YoY drop in Febr’25 unconsolidated sales, including 42% YoY decline of exports and 28% YoY decrease of domestic sales. For the 2-months of the year, unconsolidated sales were down by 10% YoY as exports were down by 10% YoY and domestic sales by 11% YoY.